Decoding the pathophysiological effects of venom and using that understanding to guide monoclonal antibody discovery for snakebite treatment.

My primary interest lies in discovering broadly neutralising monoclonal antibodies against the two of the big four snakes of India: Russell's Viper and Spectacled cobra. Apart from that, I am also interested in studying venom variation, toxins' interaction in venom, and alternative snakebite management therapies.

I serve as the Curator of the Venom Institute for Snakebite Health and Advanced Medicine (VISHAM), where I lead and manage field sampling, venom extraction, and serpentarium development initiatives. My work focuses on collecting venom from medically important snakes and supporting research on venom biology, evolution, and antivenom development. I am also actively involved in public education and outreach to improve snakebite awareness and mitigation strategies.

As a pharmacognosist, I work on identifying plant-derived bioactive compounds that can neutralize snake venom, while also exploring monoclonal antibody–based strategies for improved snakebite treatment.

I work on arthropod venoms, with a particular focus on ant venom composition and the evolution of ant venom toxins.

Natural-product drug discovery, bioassay-guided screening, and phytochemical formulation development for the advancement of auxiliary therapies against snake envenomation.

I am a Zoologist at heart. At the Evolutionary Venomics Lab, I aspire to understand species phylogenetics and phylogeography of endemic pit vipers of the Western Ghats and contribute to the Pan India development of next generation antivenom project. I also hope to unravel the role of ecology and environment in shaping the venom cocktails of these enigmatic serpents.

Preclinical evaluation of small molecule inhibitors as therapeutics against snakebite